{"DataElement":{"publicId":"12539399","version":"1","preferredName":"Procedure Domain Reported Name of Procedure Diagnostic Assessment Method Type","preferredDefinition":"The procedure name that describes the type of assessment method used for diagnosis.","longName":"PR_PRTYP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6411454","version":"1","preferredName":"Procedure Domain Reported Name of Procedure","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The literal identifier of the procedure.","longName":"6407261v1.0:6411452v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407261","version":"1","preferredName":"Procedure Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure.","longName":"C102700","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Procedure Domain","conceptCode":"C102700","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3626C-19A3-3896-E053-F662850A4518","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6411452","version":"1","preferredName":"Reported Name of Procedure","preferredDefinition":"The literal identifier of the procedure.","longName":"C117511","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reported Name of Procedure","conceptCode":"C117511","definition":"The literal identifier of the procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74229DA7-7B00-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"ONEDATA","dateModified":"2018-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"74229DA7-7B11-77CA-E053-F662850AEC9E","latestVersionIndicator":"Yes","beginDate":"2018-08-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-23","modifiedBy":"TAYLORT","dateModified":"2020-07-20","changeDescription":"7-20-20 tmt released. Created as part of the CDISC mapping task_ghd_08.23.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7348633","version":"1","preferredName":"Diagnostic Assessment Method Type","preferredDefinition":"Characteristic or indicative of a condition._The final result of a determination of the value, significance, or extent of._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Something distinguishable as an identifiable class based on common qualities.","longName":"7348633v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Laryngoscopy","valueDescription":"Laryngoscopy","ValueMeaning":{"publicId":"2832055","version":"1","preferredName":"Laryngoscopy","longName":"2832055","preferredDefinition":"Endoscopic examination of the larynx.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laryngoscopy","conceptCode":"C16781","definition":"Endoscopic examination of the larynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6209D181-B2E7-70F8-E040-BB89AD431341","latestVersionIndicator":"Yes","beginDate":"2009-02-03","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-03","modifiedBy":"ONEDATA","dateModified":"2009-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43EE-4A4C-E053-4EBD850AB273","beginDate":"2015-02-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Laparoscopy","valueDescription":"Laparoscopy","ValueMeaning":{"publicId":"2559024","version":"1","preferredName":"Laparoscopy","longName":"2559024","preferredDefinition":"(lap-a-RAHS-ko-pee) The insertion of a thin, lighted tube (called a laparoscope) through the abdominal wall to inspect the inside of the abdomen and remove tissue samples.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laparoscopy","conceptCode":"C16969","definition":"A surgical procedure during which a laparoscope is inserted into the abdomen to view the abdominopelvic contents for diagnostic and/or therapeutic purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B39D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COLBERTM","dateModified":"2022-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43DA-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Laparotomy","valueDescription":"LAPAROTOMY","ValueMeaning":{"publicId":"2559025","version":"1","preferredName":"LAPAROTOMY","longName":"2559025","preferredDefinition":"LAPAROTOMY","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laparotomy","conceptCode":"C15266","definition":"Creation of a surgical opening into the abdominal cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B39E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43E4-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Liver Biopsy","valueDescription":"Liver Biopsy","ValueMeaning":{"publicId":"2831213","version":"1","preferredName":"Liver Biopsy","longName":"2831213","preferredDefinition":"Removal of tissue from the liver for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Biopsy","conceptCode":"C51677","definition":"Removal of tissue from the liver for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62052824-8E1F-882D-E040-BB89AD4369F9","latestVersionIndicator":"Yes","beginDate":"2009-02-03","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43F8-4A4C-E053-4EBD850AB273","beginDate":"2015-10-29","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Liver MRI","valueDescription":"Liver Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7147344","version":"1","preferredName":"Liver Magnetic Resonance Imaging","longName":"7147344","preferredDefinition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CA7BAFE-E748-09B9-E053-F662850AD0C4","latestVersionIndicator":"Yes","beginDate":"2020-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-01-21","modifiedBy":"ONEDATA","dateModified":"2020-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4402-4A4C-E053-4EBD850AB273","beginDate":"2020-01-21","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"T1 MRI","valueDescription":"Longitudinal Relaxation Time Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7348631","version":"1","preferredName":"Longitudinal Relaxation Time Magnetic Resonance Imaging","longName":"7348631","preferredDefinition":"The time it takes for the net nuclear spin in the plane that is parallel to the magnetic field of a spectrometer to return to its equilibrium value.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Longitudinal Relaxation Time","conceptCode":"C80363","definition":"The time it takes for the net nuclear spin in the plane that is parallel to the magnetic field of a spectrometer to return to its equilibrium value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A98D0BEA-DF3E-5D76-E053-4EBD850ADCC4","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9AC0C0F-2FB3-252F-E053-4EBD850A0EA9","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Lymphangiogram","valueDescription":"Lymphangiogram","ValueMeaning":{"publicId":"2573980","version":"1","preferredName":"Lymphangiogram","longName":"2573980","preferredDefinition":"An x-ray image of the lymphatic system using a radiopaque imaging agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphangiogram","conceptCode":"C16805","definition":"An x-ray image of the lymphatic system using a radiopaque imaging agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-29","modifiedBy":"KUMMEROA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-440C-4A4C-E053-4EBD850AB273","beginDate":"2009-01-15","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Mammogram","valueDescription":"Mammogram","ValueMeaning":{"publicId":"2561001","version":"1","preferredName":"Mammogram","longName":"2561001","preferredDefinition":"A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mammogram","conceptCode":"C20178","definition":"A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BB56-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-04-11","endDate":null,"createdBy":"JASUR","dateCreated":"2002-04-11","modifiedBy":"REEVESD","dateModified":"2012-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4420-4A4C-E053-4EBD850AB273","beginDate":"2005-10-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Mass spectrometry","valueDescription":"Mass Spectrometry","ValueMeaning":{"publicId":"3339145","version":"1","preferredName":"Mass Spectrometry","longName":"3339145","preferredDefinition":"An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mass Spectrometry","conceptCode":"C17156","definition":"An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CBC6F0-09E2-06B9-E040-BB89AD434070","latestVersionIndicator":"Yes","beginDate":"2011-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-442A-4A4C-E053-4EBD850AB273","beginDate":"2019-06-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Mastectomy","valueDescription":"Mastectomy","ValueMeaning":{"publicId":"2559154","version":"1","preferredName":"Mastectomy","longName":"2559154","preferredDefinition":"Surgical removal of the breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mastectomy","conceptCode":"C15277","definition":"Surgical removal of the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B41F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2012-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4434-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Molecular Analysis","valueDescription":"Molecular Analysis","ValueMeaning":{"publicId":"2861224","version":"1","preferredName":"Molecular Analysis","longName":"2861224","preferredDefinition":"Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"679D66C6-463D-310F-E040-BB89AD4302D9","latestVersionIndicator":"Yes","beginDate":"2009-04-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-445C-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Molecular assay","valueDescription":"Molecular Assay","ValueMeaning":{"publicId":"7246030","version":"1","preferredName":"Molecular Assay","longName":"7246030","preferredDefinition":"Relating to or produced by or consisting of molecules.: A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A35527FA-D4C1-713E-E053-F662850AF23A","latestVersionIndicator":"Yes","beginDate":"2020-04-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-04-15","modifiedBy":"ONEDATA","dateModified":"2020-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4466-4A4C-E053-4EBD850AB273","beginDate":"2020-04-15","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Morphology","valueDescription":"Morphology","ValueMeaning":{"publicId":"4661331","version":"1","preferredName":"Morphology","longName":"4661331","preferredDefinition":"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Morphology","conceptCode":"C17943","definition":"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C444E7C-3137-DFDC-E050-BB89AD43071A","latestVersionIndicator":"Yes","beginDate":"2015-01-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4470-4A4C-E053-4EBD850AB273","beginDate":"2017-01-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRA","valueDescription":"MRI-Based Angiogram","ValueMeaning":{"publicId":"4723855","version":"1","preferredName":"MRI-Based Angiogram","longName":"4723855v1.00","preferredDefinition":"An image of blood vessels constructed using magnetic resonance imaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MRI-Based Angiogram","conceptCode":"C114867","definition":"An image of blood vessels constructed using magnetic resonance imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDC9539-B141-CB07-E050-BB89AD436926","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-447A-4A4C-E053-4EBD850AB273","beginDate":"2015-02-24","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRI","valueDescription":"Magnetic Resonance Imaging","ValueMeaning":{"publicId":"5039993","version":"1","preferredName":"Magnetic Resonance Imaging","longName":"5039993v1.00","preferredDefinition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"233FC674-C07D-D046-E050-BB89AD432339","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-10-29","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4484-4A4C-E053-4EBD850AB273","beginDate":"2015-10-29","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRI + DWI","valueDescription":"MRI DWI","ValueMeaning":{"publicId":"4253231","version":"1","preferredName":"MRI DWI","longName":"4253231","preferredDefinition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.: A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diffusion Weighted Imaging","conceptCode":"C111116","definition":"A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5890B4B-742F-B100-E040-BB89AD435FC5","latestVersionIndicator":"Yes","beginDate":"2014-03-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2014-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"8/4/2015: Restored to original format/tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4499-4A4C-E053-4EBD850AB273","beginDate":"2014-03-26","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MUGA scan","valueDescription":"MUGA Scan","ValueMeaning":{"publicId":"2571740","version":"1","preferredName":"MUGA Scan","longName":"2571740","preferredDefinition":"A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multigated Acquisition Scan","conceptCode":"C38073","definition":"A diagnostic test used to evaluate the pumping function of the heart's ventricles. A radioactive tracer is injected into a vein and a gamma camera detects the radiation released by the tracer, with image acquisition triggered (gated) at different points of the cardiac cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E549-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-19","modifiedBy":"ZHANGWE","dateModified":"2015-02-23","changeDescription":"Concept annotation added for UPitt/TCGA.  WZhang, 02/23/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4507-4A4C-E053-4EBD850AB273","beginDate":"2005-10-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Multicolor flow cytometry","valueDescription":"Multiple Color Flow Cytometry","ValueMeaning":{"publicId":"7246031","version":"1","preferredName":"Multiple Color Flow Cytometry","longName":"7246031","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.: The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Color","conceptCode":"C37927","definition":"The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A35527FA-D4E8-713E-E053-F662850AF23A","latestVersionIndicator":"Yes","beginDate":"2020-04-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-04-15","modifiedBy":"ONEDATA","dateModified":"2020-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4511-4A4C-E053-4EBD850AB273","beginDate":"2020-04-15","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Myelin-Associated Glycoprotein","valueDescription":"Myelin-Associated Glycoprotein","ValueMeaning":{"publicId":"4811579","version":"1","preferredName":"Myelin-Associated Glycoprotein","longName":"4811579","preferredDefinition":"An autoantibody directed against myelin-associated glycoprotein (MAG). It is associated with active demyelination in peripheral neuropathy and is detected in about 50% of patients with IgM paraproteinemia and may occur in some patients with multiple sclerosis, Guillain-Barre syndrome, chronic polyneuropathy, or myasthenia gravis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelin-Associated Glycoprotein Antibody","conceptCode":"C121771","definition":"An autoantibody directed against myelin-associated glycoprotein (MAG). It is associated with active demyelination in peripheral neuropathy and is detected in about 50% of patients with IgM paraproteinemia and may occur in some patients with multiple sclerosis, Guillain-Barre syndrome, chronic polyneuropathy, or myasthenia gravis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"156BA48F-ADEA-18E5-E050-BB89AD433648","latestVersionIndicator":"Yes","beginDate":"2015-05-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-451B-4A4C-E053-4EBD850AB273","beginDate":"2015-05-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Next generation sequencing (NGS)","valueDescription":"Next Generation Sequencing","ValueMeaning":{"publicId":"4448577","version":"1","preferredName":"Next Generation Sequencing","longName":"4448577","preferredDefinition":"Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Next Generation Sequencing","conceptCode":"C101293","definition":"Technologies that facilitate the rapid determination of the nucleotide sequence of large numbers of strands or segments of DNA or RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00760948-0C1D-42C2-E050-BB89AD434284","latestVersionIndicator":"Yes","beginDate":"2014-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-08-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4539-4A4C-E053-4EBD850AB273","beginDate":"2018-06-04","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Next generation sequencing (NGS) by FoundationOne","valueDescription":"FoundationOne Genomic Profiling","ValueMeaning":{"publicId":"7334408","version":"1","preferredName":"FoundationOne Genomic Profiling","longName":"7334408","preferredDefinition":"A set of proprietary genomic profiling techniques that utilize next generation sequencing. FoundationOne CDX is optimized for PPFE samples from solid tumors; FoundationOne Liquid is optimized for peripheral whole blood, targeting solid tumors; FoundationOne Heme is optimized for leukemias, lymphomas, sarcomas, and solid tumors using RNA sequencing on samples obtained from FFPE, peripheral whole blood, or bone marrow aspirate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FoundationOne Genomic Profiling","conceptCode":"C172873","definition":"A set of proprietary genomic profiling techniques that utilize next generation sequencing. FoundationOne CDX is optimized for PPFE samples from solid tumors; FoundationOne Liquid is optimized for peripheral whole blood, targeting solid tumors; FoundationOne Heme is optimized for leukemias, lymphomas, sarcomas, and solid tumors using RNA sequencing on samples obtained from FFPE, peripheral whole blood, or bone marrow aspirate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84AB85A-D837-691D-E053-4EBD850AE61F","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4543-4A4C-E053-4EBD850AB273","beginDate":"2020-06-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Next generation sequencing (NGS) by Guardant360","valueDescription":"Guardant360 Genomic Profiling","ValueMeaning":{"publicId":"7334407","version":"1","preferredName":"Guardant360 Genomic Profiling","longName":"7334407","preferredDefinition":"A proprietary genomic profiling system that utilizes a proprietary next generation Digital Sequencing technology on samples obtain from blood. It is designed to detect alterations in over 70 genes relevant to multiple solid tumor types.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Guardant360 Genomic Profiling","conceptCode":"C172874","definition":"A proprietary genomic profiling system that utilizes a proprietary next generation Digital Sequencing technology on samples obtain from blood. It is designed to detect alterations in over 70 genes relevant to multiple solid tumor types.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84AB85A-D812-691D-E053-4EBD850AE61F","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-06-17","modifiedBy":"ONEDATA","dateModified":"2020-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-454D-4A4C-E053-4EBD850AB273","beginDate":"2020-06-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-456B-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Not done","valueDescription":"NOT DONE","ValueMeaning":{"publicId":"2559596","version":"1","preferredName":"NOT DONE","longName":"2559596","preferredDefinition":"NOT DONE","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not done","conceptCode":"CL281691","definition":"No value exists.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5D9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4575-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Not Evaluated","ValueMeaning":{"publicId":"2570488","version":"1","preferredName":"Not Evaluated","longName":"2570488","preferredDefinition":"The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-457F-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4589-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4593-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Pathologic","valueDescription":"Pathologic","ValueMeaning":{"publicId":"2559724","version":"1","preferredName":"Pathologic","longName":"2559724","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B659-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Removed redundant concept. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-45A7-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Pathologic confirmation","valueDescription":"Pathologic Confirmation","ValueMeaning":{"publicId":"5633738","version":"1","preferredName":"Pathologic Confirmation","longName":"5633738","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.: Having been established or verified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F1F0BC-D0C6-1315-E053-F662850A47BA","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GRANTD","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-45B1-4A4C-E053-4EBD850AB273","beginDate":"2017-09-12","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Pitted Erythrocyte Count","valueDescription":"Pitted Erythrocyte Count","ValueMeaning":{"publicId":"7320618","version":"1","preferredName":"Pitted Erythrocyte Count","longName":"7320618","preferredDefinition":"The number of pitted erythrocytes in a blood sample, expressed as a percentage. It is used as an indicator of splenic function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pitted Erythrocyte Count","conceptCode":"C172658","definition":"The number of pitted erythrocytes in a blood sample, expressed as a percentage. It is used as an indicator of splenic function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7A718BA-CBC0-05DC-E053-4EBD850A3F0C","latestVersionIndicator":"Yes","beginDate":"2020-06-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-06-09","modifiedBy":"ONEDATA","dateModified":"2020-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-461F-4A4C-E053-4EBD850AB273","beginDate":"2020-06-09","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Polymerase Chain Reaction","valueDescription":"Polymerase Chain Reaction","ValueMeaning":{"publicId":"3234683","version":"1","preferredName":"Polymerase Chain Reaction","longName":"3234683","preferredDefinition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1572-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":"7-20-20 TMT updated concept with NCIt definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4647-4A4C-E053-4EBD850AB273","beginDate":"2012-10-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Preoperative CT Scan","valueDescription":"Preoperative Computed Tomography","ValueMeaning":{"publicId":"6332631","version":"1","preferredName":"Preoperative Computed Tomography","longName":"6332631","preferredDefinition":"Relating to or occurring during the period immediately before a surgical operation.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preoperative","conceptCode":"C54732","definition":"Relating to or occurring during the period immediately before a surgical operation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6DFF9B37-C6AC-2472-E053-F662850A1D9E","latestVersionIndicator":"Yes","beginDate":"2018-06-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-06-06","modifiedBy":"ONEDATA","dateModified":"2018-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4667-4A4C-E053-4EBD850AB273","beginDate":"2018-06-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Prophalactic mastectomy","valueDescription":"Prophylactic Mastectomy","ValueMeaning":{"publicId":"2559913","version":"1","preferredName":"Prophylactic Mastectomy","longName":"2559913","preferredDefinition":"Surgery to reduce the risk of developing breast cancer by removing one or both breasts before disease develops.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prophylactic Mastectomy","conceptCode":"C94445","definition":"Surgery to reduce the risk of developing breast cancer by removing one or both breasts before disease develops.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B716-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Added concept and corrected typo in Long Name. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4685-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"PSA Assessment","valueDescription":"Prostate-Specific Antigen","ValueMeaning":{"publicId":"2580427","version":"1","preferredName":"Prostate-Specific Antigen","longName":"2580427","preferredDefinition":"Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0738-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-468F-4A4C-E053-4EBD850AB273","beginDate":"2006-10-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Radiographic confirmation only","valueDescription":"Radiographic Examination Confirmation Only","ValueMeaning":{"publicId":"5977653","version":"1","preferredName":"Radiographic Examination Confirmation Only","longName":"5977653v1.00","preferredDefinition":"A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation._Having been established or verified._Not accompanied by another or others; exclusive of anyone or anything else.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiographic Examination","conceptCode":"C128940","definition":"A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58FEB590-FC0E-6B90-E053-F662850A2EAA","latestVersionIndicator":"Yes","beginDate":"2017-09-12","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-09-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-46B7-4A4C-E053-4EBD850AB273","beginDate":"2017-09-12","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Radiographic Imaging","valueDescription":"Radiograph Imaging Technique","ValueMeaning":{"publicId":"3626193","version":"1","preferredName":"Radiograph Imaging Technique","longName":"3626193","preferredDefinition":"An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiograph","conceptCode":"C60727","definition":"An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE634359-F35B-7F28-E040-BB89AD437B44","latestVersionIndicator":"Yes","beginDate":"2012-11-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-11-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-46C1-4A4C-E053-4EBD850AB273","beginDate":"2012-11-13","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Right Heart Catheterization","valueDescription":"Right Heart Catheterization","ValueMeaning":{"publicId":"7244953","version":"1","preferredName":"Right Heart Catheterization","longName":"7244953","preferredDefinition":"A diagnostic procedure in which a catheter is guided into the right heart, where pressures may be measured and radiocontrast material may be injected to visualize blood flow in and around the right heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Right Heart Catheterization","conceptCode":"C80411","definition":"A diagnostic procedure in which a catheter is guided into the right heart, where pressures may be measured and radiocontrast material may be injected to visualize blood flow in and around the right heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2F2A595-9D9C-37DB-E053-F662850AD1A7","latestVersionIndicator":"Yes","beginDate":"2020-04-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-46F4-4A4C-E053-4EBD850AB273","beginDate":"2020-04-10","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Serological","valueDescription":"Serology","ValueMeaning":{"publicId":"2562238","version":"1","preferredName":"Serology","longName":"2562238","preferredDefinition":"Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serological","conceptCode":"C41264","definition":"Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C02B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-05","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-05","modifiedBy":"CAMPBELB","dateModified":"2014-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4708-4A4C-E053-4EBD850AB273","beginDate":"2009-02-09","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Serum ferritin","valueDescription":"Serum Ferritin Measurement","ValueMeaning":{"publicId":"7147345","version":"1","preferredName":"Serum Ferritin Measurement","longName":"7147345","preferredDefinition":"The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.: The determination of the amount of ferritin present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ferritin Measurement","conceptCode":"C74737","definition":"The determination of the amount of ferritin present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CA7BAFE-E76E-09B9-E053-F662850AD0C4","latestVersionIndicator":"Yes","beginDate":"2020-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-01-21","modifiedBy":"ONEDATA","dateModified":"2020-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4712-4A4C-E053-4EBD850AB273","beginDate":"2020-01-21","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Shell Vial Culture","valueDescription":"Shell Vial Culture","ValueMeaning":{"publicId":"4262871","version":"1","preferredName":"Shell Vial Culture","longName":"4262871","preferredDefinition":"A method for virus culture and detection in which a virus sample is mixed with a susceptible cell type and then centrifuged into a single layer of cells. Following a short incubation, viral growth is determined using immunological detection techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shell Vial Culture","conceptCode":"C114597","definition":"A method for virus culture and detection in which a virus sample is mixed with a susceptible cell type and then centrifuged into a single layer of cells. Following a short incubation, viral growth is determined using immunological detection techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6387D07-36B4-1F37-E040-BB89AD4364EC","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-471C-4A4C-E053-4EBD850AB273","beginDate":"2014-04-04","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Sokal","valueDescription":"Sokal Score","ValueMeaning":{"publicId":"5485916","version":"1","preferredName":"Sokal Score","longName":"5485916","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sokal Score","conceptCode":"C127875","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-8483-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-473A-4A4C-E053-4EBD850AB273","beginDate":"2016-09-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Spiral CT","valueDescription":"Spiral CT","ValueMeaning":{"publicId":"2970362","version":"1","preferredName":"Spiral CT","longName":"2970362","preferredDefinition":"A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spiral CT","conceptCode":"C20645","definition":"A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AEF618B-EF7A-5E22-E040-BB89AD4361C7","latestVersionIndicator":"Yes","beginDate":"2009-12-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4744-4A4C-E053-4EBD850AB273","beginDate":"2009-12-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Splenic Scan","valueDescription":"Splenic Scan","ValueMeaning":{"publicId":"7331906","version":"1","preferredName":"Splenic Scan","longName":"7331906","preferredDefinition":"A radionuclide imaging technique that is used to evaluate the size and shape of the spleen, and to detect and evaluate lesions, rupture, and hematomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Splenic Scan","conceptCode":"C172726","definition":"A radionuclide imaging technique that is used to evaluate the size and shape of the spleen, and to detect and evaluate lesions, rupture, and hematomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8223C43-8258-2F9B-E053-4EBD850A3825","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4758-4A4C-E053-4EBD850AB273","beginDate":"2020-06-15","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"SQUID","valueDescription":"Superconducting Quantum Interference Device","ValueMeaning":{"publicId":"5039992","version":"1","preferredName":"Superconducting Quantum Interference Device","longName":"5039992","preferredDefinition":"A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Superconducting Quantum Interference Device","conceptCode":"C124066","definition":"A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"233FC674-C050-D046-E050-BB89AD432339","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4762-4A4C-E053-4EBD850AB273","beginDate":"2015-10-29","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"SQUID MRI","valueDescription":"Superconducting Quantum Interference Device Magnetic Resonance Imaging","ValueMeaning":{"publicId":"6576956","version":"1","preferredName":"Superconducting Quantum Interference Device Magnetic Resonance Imaging","longName":"6576956","preferredDefinition":"A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Superconducting Quantum Interference Device","conceptCode":"C124066","definition":"A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C35A471-E0E4-7B2A-E053-F662850A79BC","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-12-04","modifiedBy":"ONEDATA","dateModified":"2018-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-476C-4A4C-E053-4EBD850AB273","beginDate":"2018-12-04","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgery","ValueMeaning":{"publicId":"2560125","version":"1","preferredName":"Surgery","longName":"2560125","preferredDefinition":"A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4776-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"T2 MRI","valueDescription":"T2 (Observed)-Weighted Imaging","ValueMeaning":{"publicId":"6576930","version":"1","preferredName":"T2 (Observed)-Weighted Imaging","longName":"6576930","preferredDefinition":"MRI imaging based on the observed T2 relaxation time of tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 (Observed)-Weighted Imaging","conceptCode":"C156447","definition":"MRI imaging based on the observed T2 relaxation time of tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C35BE4D-903B-20EB-E053-F662850A473E","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-12-04","modifiedBy":"KUMMEROA","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":"2023.7.24 Alt VM added per ticket request CADSR0002644. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4780-4A4C-E053-4EBD850AB273","beginDate":"2018-12-04","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Transrectal ultrasound","valueDescription":"Transrectal Ultrasound","ValueMeaning":{"publicId":"2581622","version":"1","preferredName":"Transrectal Ultrasound","longName":"2581622","preferredDefinition":"A procedure that uses sound waves to create a video image of the prostate gland. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter the prostate. Prostate tumors sometimes create echoes that are different from normal prostate tissue. The echoes that bounce back are sent to a computer that translates the pattern of echoes into a picture of the prostate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transrectal Ultrasound","conceptCode":"C18315","definition":"A procedure that uses sound waves to create a video image of the pelvic organs and tissues. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter a pelvic organ. The echoes that bounce back are sent to a computer that translates the pattern of echoes into a picture of the specific organ under examination.  This procedure is most often used to evaluate the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-19","modifiedBy":"CURTIST","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-478A-4A4C-E053-4EBD850AB273","beginDate":"2007-08-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Ultrasound","valueDescription":"Ultrasound","ValueMeaning":{"publicId":"2570770","version":"1","preferredName":"Ultrasound","longName":"2570770","preferredDefinition":"Very high frequency sound. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ultrasound","conceptCode":"C64384","definition":"High frequency sound, generally with a frequency greater than 20,000 Hz.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E17F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-28","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CURTIST","dateModified":"2007-03-28","changeDescription":"03/28/2007 - Updated with NCI Thesaurus definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-47A8-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-47B2-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"2-D Echocardiogram","valueDescription":"2-D Echocardiogram","ValueMeaning":{"publicId":"2847201","version":"1","preferredName":"2-D Echocardiogram","longName":"2847201","preferredDefinition":"The property of being measured and described using two orthogonal directions.: An image of the heart produced by ultrasonography.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"2-Dimensional","conceptCode":"C48282","definition":"The property of being measured and described using two orthogonal directions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Echocardiogram Recording","conceptCode":"C37945","definition":"An image of the heart produced by ultrasonography.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B1C7AC-4716-B4AC-E040-BB89AD43401F","latestVersionIndicator":"Yes","beginDate":"2009-03-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-03-09","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Added concept annotation. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3F81-4A4C-E053-4EBD850AB273","beginDate":"2009-03-09","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Abdominal CT","valueDescription":"Abdominal CT-scan","ValueMeaning":{"publicId":"2667062","version":"1","preferredName":"Abdominal CT-scan","longName":"2667062","preferredDefinition":"Of, or related to, the abdomen.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal","conceptCode":"C25342","definition":"Of, or related to, the abdomen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36062970-5F9B-6D33-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-07-24","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Added concept annotation. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3F8B-4A4C-E053-4EBD850AB273","beginDate":"2007-08-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Abdominal MRI","valueDescription":"Abdominal MRI","ValueMeaning":{"publicId":"2673036","version":"1","preferredName":"Abdominal MRI","longName":"2673036","preferredDefinition":"Of, or related to, the abdomen.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal","conceptCode":"C25342","definition":"Of, or related to, the abdomen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37E5F0E7-7256-6BE9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-08-17","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3F95-4A4C-E053-4EBD850AB273","beginDate":"2007-08-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Antigen","valueDescription":"Antigen","ValueMeaning":{"publicId":"3167779","version":"1","preferredName":"Antigen","longName":"3167779","preferredDefinition":"Any substance that appears foreign or potentially adverse to the body and elicits immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"977E0E2F-20C3-9A91-E040-BB89AD434AE4","latestVersionIndicator":"Yes","beginDate":"2010-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3F9F-4A4C-E053-4EBD850AB273","beginDate":"2014-04-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Biopsy other","valueDescription":"Other Biopsy","ValueMeaning":{"publicId":"3953012","version":"1","preferredName":"Other Biopsy","longName":"3953012","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB40BAD6-A75C-DCA5-E040-BB89AD437A9D","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-92ED-2398-E053-4EBD850AD8F9","beginDate":"2002-12-19","endDate":"2012-07-10","createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Chimerism testing","valueDescription":"Chimerism Test","ValueMeaning":{"publicId":"7496364","version":"1","preferredName":"Chimerism Test","longName":"7496364","preferredDefinition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimerism","conceptCode":"C62582","definition":"The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373A6EB-92FB-2398-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-9314-2398-E053-4EBD850AD8F9","beginDate":"2015-11-10","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"FDG-PET","valueDescription":"Fludeoxyglucose F-18 Positron Emission Tomography","ValueMeaning":{"publicId":"7496365","version":"1","preferredName":"Fludeoxyglucose F-18 Positron Emission Tomography","longName":"7496365","preferredDefinition":"The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fludeoxyglucose F-18","conceptCode":"C964","definition":"A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373A6EB-931E-2398-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-9337-2398-E053-4EBD850AD8F9","beginDate":"2009-07-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"PET/Conventional CT","valueDescription":"Positron Emission Tomography Computed Tomography","ValueMeaning":{"publicId":"4143413","version":"1","preferredName":"Positron Emission Tomography Computed Tomography","longName":"4143413","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1C1EFF8-C78C-4796-E040-BB89AD432BC9","latestVersionIndicator":"Yes","beginDate":"2014-02-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-934B-2398-E053-4EBD850AD8F9","beginDate":"2011-05-23","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Autopsy","valueDescription":"Autopsy","ValueMeaning":{"publicId":"2567287","version":"1","preferredName":"Autopsy","longName":"2567287","preferredDefinition":"Autopsy; an examination and dissection of a dead body to determine cause of death or the changes produced by disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autopsy","conceptCode":"C25153","definition":"A postmortem examination of the body that includes an examination of the internal organs and structures after dissection to determine the cause of death and the nature of pathological changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"KUMMEROA","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3FB3-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Axillary dissection","valueDescription":"AXILLARY DISSECTION","ValueMeaning":{"publicId":"2558265","version":"1","preferredName":"AXILLARY DISSECTION","longName":"2558265","preferredDefinition":"Pertaining to the armpit area, including the lymph nodes that are located there.: The process of cutting apart or separating tissue as, for example, in the study of anatomy or in the course of a surgical procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Axillary","conceptCode":"C13351","definition":"Pertaining to the armpit area, including the lymph nodes that are located there.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dissection","conceptCode":"C15227","definition":"The process of cutting apart or separating tissue as, for example, in the study of anatomy or in the course of a surgical procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Added concept annotation. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3FBD-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"PET/Spiral CT","valueDescription":"Positron Emission Tomography Spiral CT","ValueMeaning":{"publicId":"7496366","version":"1","preferredName":"Positron Emission Tomography Spiral CT","longName":"7496366","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.: A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Spiral CT","conceptCode":"C20645","definition":"A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373A6EB-9358-2398-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-9371-2398-E053-4EBD850AD8F9","beginDate":"2011-05-23","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Bilateral mammogram","valueDescription":"Bilateral mammogram","ValueMeaning":{"publicId":"2563569","version":"1","preferredName":"Bilateral mammogram","longName":"2563569","preferredDefinition":"Affecting both sides of the body or a matched pair of organs.: A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bilateral","conceptCode":"C13332","definition":"Affecting both sides of the body or a matched pair of organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mammogram","conceptCode":"C20178","definition":"A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C55E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-11-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-11-06","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3FDB-4A4C-E053-4EBD850AB273","beginDate":"2002-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Bimanual examination","valueDescription":"BIMANUAL EXAMINATION","ValueMeaning":{"publicId":"2558295","version":"1","preferredName":"BIMANUAL EXAMINATION","longName":"2558295","preferredDefinition":"Relating to, or performed by, both hands.: A formal or careful inspection of an object or subject.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bimanual","conceptCode":"C25433","definition":"Relating to, or performed by, both hands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Examination","conceptCode":"C131902","definition":"A formal or careful inspection of an object or subject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2019-07-15","changeDescription":"Added concept annotation. mc 7/15/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3FE5-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Biopsy","valueDescription":"Biopsy","ValueMeaning":{"publicId":"2574093","version":"1","preferredName":"Biopsy","longName":"2574093","preferredDefinition":"Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE7A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2012-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-3FEF-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Physical Exam","valueDescription":"Physical Examination","ValueMeaning":{"publicId":"2581620","version":"1","preferredName":"Physical Examination","longName":"2581620","preferredDefinition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-19","modifiedBy":"COOPERM","dateModified":"2019-04-23","changeDescription":"Updated definition to match current NCIt. mc 4.23.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-937B-2398-E053-4EBD850AD8F9","beginDate":"2020-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Bone Marrow Aspirate","valueDescription":"Aspirate, Bone Marrow","ValueMeaning":{"publicId":"2573943","version":"1","preferredName":"Aspirate, Bone Marrow","longName":"2573943","preferredDefinition":"(as-per-AY-shun) The removal of a small sample of bone marrow (usually from the hip) through a needle for examination under a microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow Aspiration","conceptCode":"C15644","definition":"Aspiration of immature hematopoietic elements and blood from the bone marrow.  It is done for the evaluation of hematopoietic disorders and for the evaluation of infectious diseases and cytogenetic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EDE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-29","modifiedBy":"REEVESD","dateModified":"2007-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4004-4A4C-E053-4EBD850AB273","beginDate":"2009-08-20","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Bone Marrow Biopsy","valueDescription":"BONE MARROW BIOPSY","ValueMeaning":{"publicId":"2562182","version":"1","preferredName":"BONE MARROW BIOPSY","longName":"2562182","preferredDefinition":"BONE MARROW BIOPSY","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow Biopsy","conceptCode":"C15193","definition":"A biopsy involving the removal of a core tissue containing bone spicules and hematopoietic elements embedded in the marrow stroma.  This procedure is done in the hip area mainly for the diagnosis and evaluation of neoplastic and non-neoplastic hematopoietic disorders (e.g. anemias, leukemias, lymphomas) and the evaluation of the spread of solid tumors (e.g. carcinomas, sarcomas) and lymphomas for therapeutic purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BFF3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-01","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-08-01","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-400E-4A4C-E053-4EBD850AB273","beginDate":"2009-08-20","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Physical examination with imaging","valueDescription":"Physical Examination And Imaging Technique","ValueMeaning":{"publicId":"7496367","version":"1","preferredName":"Physical Examination And Imaging Technique","longName":"7496367","preferredDefinition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373A6EB-9389-2398-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-93A2-2398-E053-4EBD850AD8F9","beginDate":"2013-09-24","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Bone scan","valueDescription":"Bone Scan","ValueMeaning":{"publicId":"2558319","version":"1","preferredName":"Bone Scan","longName":"2558319","preferredDefinition":"A nuclear imaging method used to evaluate pathological bone metabolism. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Scan","conceptCode":"C17646","definition":"A nuclear imaging method used to evaluate pathological bone metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2012-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4022-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Both","valueDescription":"Both","ValueMeaning":{"publicId":"5612442","version":"1","preferredName":"Both","longName":"5612442","preferredDefinition":"One and the other; relating to or being two in conjunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"453584A6-3600-15AA-E053-F662850A2541","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-402C-4A4C-E053-4EBD850AB273","beginDate":"2018-05-21","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Bronchoscopy","valueDescription":"Bronchoscopy","ValueMeaning":{"publicId":"2566854","version":"1","preferredName":"Bronchoscopy","longName":"2566854","preferredDefinition":"A procedure in which a thin, lighted tube is inserted through the nose or mouth. NCI Concept Code C16366","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchoscopy","conceptCode":"C16366","definition":"Endoscopic examination of the tracheobronchial tree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D233-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"DWARZEL","dateCreated":"2003-08-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4036-4A4C-E053-4EBD850AB273","beginDate":"2007-05-22","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"PSMA PET Scan","valueDescription":"FOLH1 wt Allele Positron Emission Tomography","ValueMeaning":{"publicId":"7496369","version":"1","preferredName":"FOLH1 wt Allele Positron Emission Tomography","longName":"7496369","preferredDefinition":"Human FOLH1 wild-type allele is located in the vicinity of 11p11.2 and is approximately 62 kb in length. This allele, which encodes glutamate carboxypeptidase 2 protein, plays a role in both the uptake of folate in the intestine and the hydrolysis of N-aceylaspartylglutamate, the major neurotransmitter in the brain. This gene is overexpressed in human prostate cancer and may inhibit metastasis of this disease.: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FOLH1 wt Allele","conceptCode":"C49386","definition":"Human FOLH1 wild-type allele is located in the vicinity of 11p11.2 and is approximately 62 kb in length. This allele, which encodes glutamate carboxypeptidase 2 protein, plays a role in both the uptake of folate in the intestine and the hydrolysis of N-aceylaspartylglutamate, the major neurotransmitter in the brain. This gene is overexpressed in human prostate cancer and may inhibit metastasis of this disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373A6EB-93B0-2398-E053-4EBD850AD8F9","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-93C9-2398-E053-4EBD850AD8F9","beginDate":"2018-08-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Caliper measurement by clinical exam","valueDescription":"Vernier Caliper Measurement Physical Examination","ValueMeaning":{"publicId":"3131893","version":"1","preferredName":"Vernier Caliper Measurement Physical Examination","longName":"3131893","preferredDefinition":"A medical device that is a combination of ruler and caliper that can measure the distance between two points. The configuration of this device permits the measurement of internal dimensions.: Measurement; the size or magnitude of something.: A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual's health assessment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vernier Caliper","conceptCode":"C81184","definition":"A medical device that is a combination of ruler and caliper that can measure the distance between two points. The configuration of this device permits the measurement of internal dimensions.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E93E677-3DC7-3E06-E040-BB89AD434760","latestVersionIndicator":"Yes","beginDate":"2010-08-24","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-404A-4A4C-E053-4EBD850AB273","beginDate":"2010-08-24","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Capillary electrophoresis","valueDescription":"Capillary Electrophoresis","ValueMeaning":{"publicId":"2915741","version":"1","preferredName":"Capillary Electrophoresis","longName":"2915741","preferredDefinition":"An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. Due to the large surface to volume ratio, cooling is more efficient, allowing use of higher voltages.  As a result, separation occurs more quickly and sensitivity is increased. The technique allows for separation of proteins, nucleic acids, and carbohydrates.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capillary Electrophoresis","conceptCode":"C17637","definition":"An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. Due to the large surface to volume ratio, cooling is more efficient, allowing use of higher voltages.  As a result, separation occurs more quickly and sensitivity is increased. The technique allows for separation of proteins, nucleic acids, and carbohydrates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E33206B-578F-2E5D-E040-BB89AD434538","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4054-4A4C-E053-4EBD850AB273","beginDate":"2018-10-08","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"CARTOX","valueDescription":"CARTOX 10 Point Neurological Assessment","ValueMeaning":{"publicId":"6927188","version":"1","preferredName":"CARTOX 10 Point Neurological Assessment","longName":"6927188","preferredDefinition":"A test to monitor for neurotoxicity related to CAR T therapy: orientation to year, month, city, hospital, and President; ability to name 3 specified objects; ability to write a standard sentence; ability to count backwards from 100 by 10.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CARTOX 10 Point Neurological Assessment","conceptCode":"C155295","definition":"A test to monitor for neurotoxicity related to CAR T therapy: orientation to year, month, city, hospital, and President; ability to name 3 specified objects; ability to write a standard sentence; ability to count backwards from 100 by 10.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"924E51E3-4146-3A85-E053-F662850A4336","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-09-11","modifiedBy":"ONEDATA","dateModified":"2019-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-405E-4A4C-E053-4EBD850AB273","beginDate":"2019-09-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"CEA","valueDescription":"Carcinoembryonic Antigen","ValueMeaning":{"publicId":"2633456","version":"1","preferredName":"Carcinoembryonic Antigen","longName":"2633456","preferredDefinition":"Carcinoembryonic antigen. A substance that is sometimes found in an increased amount in the blood of people with certain cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoembryonic Antigen","conceptCode":"C25159","definition":"A cancer-specific antigen associated with both tumors and the developing fetus. The main use of this antigen is as a tumor marker, especially with respect to intestinal cancers. Production of the antigen ceases shortly before birth, but may reappear in people who develop certain types of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F09EB21-601C-288C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-04-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4068-4A4C-E053-4EBD850AB273","beginDate":"2008-01-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Radiologic","valueDescription":"Radiologic Imaging Procedure","ValueMeaning":{"publicId":"4637485","version":"1","preferredName":"Radiologic Imaging Procedure","longName":"4637485","preferredDefinition":"Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiologic Imaging Procedure","conceptCode":"C118849","definition":"Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5F2708-90EF-51C5-E050-BB89AD434FAF","latestVersionIndicator":"Yes","beginDate":"2014-12-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-12-16","modifiedBy":"ONEDATA","dateModified":"2014-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373A6EB-93E0-2398-E053-4EBD850AD8F9","beginDate":"2008-10-07","endDate":"2016-01-05","createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"ELISA","valueDescription":"ELISA","ValueMeaning":{"publicId":"3173905","version":"1","preferredName":"ELISA","longName":"3173905","preferredDefinition":"A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attatched, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ELISA","conceptCode":"C16553","definition":"A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-368B-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-12-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B372E45D-B888-53A1-E053-4EBD850A4784","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Clinical","valueDescription":"Clinical","ValueMeaning":{"publicId":"2568063","version":"1","preferredName":"Clinical","longName":"2568063","preferredDefinition":"Having to do with the examination and treatment of patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4090-4A4C-E053-4EBD850AB273","beginDate":"2004-02-23","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Clinical and/or hematologic analysis","valueDescription":"Clinical And/Or Hematologic Analysis","ValueMeaning":{"publicId":"3028333","version":"1","preferredName":"Clinical And/Or Hematologic Analysis","longName":"3028333","preferredDefinition":"Having to do with the examination and treatment of patients.: Used to indicate that either or both of two items or options: Pertaining to or related to the blood and blood-forming organs.: Analysis; examination and interpretation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82189A14-EA15-E09F-E040-BB89AD436C8F","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-409A-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Clinical Palpation","valueDescription":"Clinical Palpation","ValueMeaning":{"publicId":"5283971","version":"1","preferredName":"Clinical Palpation","longName":"5283971","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Palpation","conceptCode":"C16950","definition":"A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3425C607-4F99-5137-E050-BB89AD43558C","latestVersionIndicator":"Yes","beginDate":"2016-05-31","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-05-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-40B8-4A4C-E053-4EBD850AB273","beginDate":"2016-05-31","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Colonoscopy","valueDescription":"Colonoscopy","ValueMeaning":{"publicId":"2569094","version":"1","preferredName":"Colonoscopy","longName":"2569094","preferredDefinition":"Endoscopic examination of the luminal surface of the colon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colonoscopy","conceptCode":"C16450","definition":"Endoscopic examination of the luminal surface of the colon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DAF3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-08","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-04-08","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-40C2-4A4C-E053-4EBD850AB273","beginDate":"2007-05-22","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRI of the brain with orbital cuts","valueDescription":"Brain With Orbit Sequence Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7348653","version":"1","preferredName":"Brain With Orbit Sequence Magnetic Resonance Imaging","longName":"7348653","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.: Used to indicate the presence of something or someone.: The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.: A serial arrangement in which things follow in logical order or a recurrent pattern.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Orbit","conceptCode":"C12347","definition":"The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sequence","conceptCode":"C25673","definition":"A serial arrangement in which things follow in logical order or a recurrent pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9ABEBA6-0AE0-22DB-E053-4EBD850AAE76","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9ABEBA6-0AF9-22DB-E053-4EBD850AAE76","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None","ValueMeaning":{"publicId":"3030997","version":"1","preferredName":"None","longName":"3030997","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82DD865C-2FEA-9DF4-E040-BB89AD434EAA","latestVersionIndicator":"Yes","beginDate":"2010-03-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9ABEBA6-0B0D-22DB-E053-4EBD850AAE76","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRI of the Spine","valueDescription":"Spinal Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7348654","version":"1","preferredName":"Spinal Magnetic Resonance Imaging","longName":"7348654","preferredDefinition":"Of or relating to the spine or spinal cord.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spinal","conceptCode":"C38026","definition":"Of or relating to the spine or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9ABEBA6-0B1A-22DB-E053-4EBD850AAE76","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9ABEBA6-0B33-22DB-E053-4EBD850AAE76","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Complete red blood cell count","valueDescription":"Complete Erythrocyte Count","ValueMeaning":{"publicId":"7320617","version":"1","preferredName":"Complete Erythrocyte Count","longName":"7320617","preferredDefinition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The determination of the number of erythrocytes in a blood sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Erythrocyte Count","conceptCode":"C51946","definition":"The determination of the number of erythrocytes in a biospecimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7A718BA-CB9B-05DC-E053-4EBD850A3F0C","latestVersionIndicator":"Yes","beginDate":"2020-06-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-06-09","modifiedBy":"ONEDATA","dateModified":"2020-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-40EA-4A4C-E053-4EBD850AB273","beginDate":"2020-06-09","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRI of the Brain","valueDescription":"Brain Magnetic Resonance Imaging","ValueMeaning":{"publicId":"5596141","version":"1","preferredName":"Brain Magnetic Resonance Imaging","longName":"5596141","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"431792D3-B643-3A27-E053-F662850AC59B","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-07","modifiedBy":"KUMMEROA","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9ABEBA6-0B47-22DB-E053-4EBD850AAE76","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Core biopsy","valueDescription":"Core Needle Biopsy","ValueMeaning":{"publicId":"2576317","version":"1","preferredName":"Core Needle Biopsy","longName":"2576317","preferredDefinition":"The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Core Biopsy","conceptCode":"C15680","definition":"The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F72A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"REEVESD","dateModified":"2010-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4108-4A4C-E053-4EBD850AB273","beginDate":"2008-01-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"CT of Brain","valueDescription":"Computed Tomography Brain","ValueMeaning":{"publicId":"6058859","version":"1","preferredName":"Computed Tomography Brain","longName":"6058859","preferredDefinition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63EF6883-6EE1-1FE5-E053-F662850ADDFE","latestVersionIndicator":"Yes","beginDate":"2018-01-29","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-01-29","modifiedBy":"ONEDATA","dateModified":"2018-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-411C-4A4C-E053-4EBD850AB273","beginDate":"2018-01-29","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"CT scan","valueDescription":"CT Scan","ValueMeaning":{"publicId":"2570151","version":"1","preferredName":"CT Scan","longName":"2570151","preferredDefinition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"COOPERM","dateModified":"2018-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4130-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Culture","valueDescription":"Culture Procedure","ValueMeaning":{"publicId":"2577346","version":"1","preferredName":"Culture Procedure","longName":"2577346","preferredDefinition":"Any laboratory procedure for growing microorganisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microbial Culture Procedure","conceptCode":"C25300","definition":"Any laboratory procedure for growing microorganisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FB2F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2005-12-27","modifiedBy":"DWARZEL","dateModified":"2005-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-414E-4A4C-E053-4EBD850AB273","beginDate":"2011-01-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Cystoscopy","valueDescription":"Cystoscopy","ValueMeaning":{"publicId":"2569349","version":"1","preferredName":"Cystoscopy","longName":"2569349","preferredDefinition":"Endoscopic examination of the urinary bladder or urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cystoscopy","conceptCode":"C16482","definition":"Endoscopic examination of the urinary bladder or urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DBF2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-21","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-21","modifiedBy":"COOPERM","dateModified":"2019-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4158-4A4C-E053-4EBD850AB273","beginDate":"2004-06-24","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Cytogenetic Analysis","valueDescription":"Cytogenetic Analysis","ValueMeaning":{"publicId":"2861225","version":"1","preferredName":"Cytogenetic Analysis","longName":"2861225","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"679D66C6-4660-310F-E040-BB89AD4302D9","latestVersionIndicator":"Yes","beginDate":"2009-04-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4162-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Cytogenetic analysis by FISH","valueDescription":"Cytogenetic Analysis Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"3028332","version":"1","preferredName":"Cytogenetic Analysis Fluorescence in situ Hybridization","longName":"3028332","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82189A14-E9ED-E09F-E040-BB89AD436C8F","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-416C-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Cytology","valueDescription":"Cytology","ValueMeaning":{"publicId":"2558589","version":"1","preferredName":"Cytology","longName":"2558589","preferredDefinition":"Cytology; the branch of biology that studies the structure and function of cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytology","conceptCode":"C16491","definition":"The light microscopic study of normal and abnormal cells in fine needle aspirates (FNAs), body cavity fluids, and smears.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2011-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4180-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Diagnostic Imaging","valueDescription":"Diagnostic Imaging","ValueMeaning":{"publicId":"2573670","version":"1","preferredName":"Diagnostic Imaging","longName":"2573670","preferredDefinition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnostic Imaging","conceptCode":"C16502","definition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECD3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-03-21","modifiedBy":"MAESKEB","dateModified":"2005-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-419E-4A4C-E053-4EBD850AB273","beginDate":"2009-01-13","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Digital rectal exam","valueDescription":"Digital Rectal Examination","ValueMeaning":{"publicId":"2581179","version":"1","preferredName":"Digital Rectal Examination","longName":"2581179","preferredDefinition":"Digital rectal examination.  An examination in which a doctor inserts a lubricated, gloved finger into the rectum to feel for abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Digital Rectal Examination","conceptCode":"C17631","definition":"An examination that checks for abnormalities of organs or other structures in the pelvis and lower abdomen. During a digital rectal exam, a health professional inserts a lubricated, gloved finger of one hand into the rectum and may use the other hand to press on the lower abdomen or pelvic area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-10-11","modifiedBy":"REEVESD","dateModified":"2007-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-41B2-4A4C-E053-4EBD850AB273","beginDate":"2006-10-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Disease specific molecular marker","valueDescription":"Disease specific molecular marker","ValueMeaning":{"publicId":"5084231","version":"1","preferredName":"Disease specific molecular marker","longName":"5084231","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.::2: Clearly and explicitly stated.::2: A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Specified","conceptCode":"C38024","definition":"Clearly and explicitly stated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26DDCF3C-5271-5C57-E050-BB89AD430CC4","latestVersionIndicator":"Yes","beginDate":"2015-12-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-41DA-4A4C-E053-4EBD850AB273","beginDate":"2015-12-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Ductal lavage","valueDescription":"DUCTAL LAVAGE","ValueMeaning":{"publicId":"2558693","version":"1","preferredName":"DUCTAL LAVAGE","longName":"2558693","preferredDefinition":"DUCTAL LAVAGE","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ductal lavage","conceptCode":"CL054589","definition":"A method used to collect cells from milk ducts in the breast.  The cells are looked at under a microscope to check for cancer.  A hair-size catheter (tube) is inserted into the nipple.  A small amount of salt water flows into the duct and is then removed with the cells in it.  Ductal lavage may be used in addition to physical breast examination and mammography to detect breast cancer.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B252-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-41E4-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Echocardiogram","valueDescription":"Echocardiogram","ValueMeaning":{"publicId":"2566540","version":"1","preferredName":"Echocardiogram","longName":"2566540","preferredDefinition":"An image of the heart produced by ultrasonography.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Echocardiogram Recording","conceptCode":"C37945","definition":"An image of the heart produced by ultrasonography.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-12","modifiedBy":"REEVESD","dateModified":"2012-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4202-4A4C-E053-4EBD850AB273","beginDate":"2005-10-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Electromyography","valueDescription":"Electromyography","ValueMeaning":{"publicId":"4821875","version":"1","preferredName":"Electromyography","longName":"4821875","preferredDefinition":"An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electromyography","conceptCode":"C38056","definition":"An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1592176B-2BA6-7175-E050-BB89AD430752","latestVersionIndicator":"Yes","beginDate":"2015-05-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-05-08","modifiedBy":"COLBERTM","dateModified":"2022-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4216-4A4C-E053-4EBD850AB273","beginDate":"2015-05-07","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Endoscopy","valueDescription":"Endoscopy","ValueMeaning":{"publicId":"2558723","version":"1","preferredName":"Endoscopy","longName":"2558723","preferredDefinition":"(en-DAHS-ko-pee) The use of a thin, lighted tube (called an endoscope) to examine the inside of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endoscopic Procedure","conceptCode":"C16546","definition":"A diagnostic or therapeutic procedure in which an endoscope is inserted in a tubular organ to examine the structural architecture and/or remove abnormal tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B270-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COLBERTM","dateModified":"2022-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4220-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"EUTOS","valueDescription":"European Treatment Outcome Study Score","ValueMeaning":{"publicId":"5485918","version":"1","preferredName":"European Treatment Outcome Study Score","longName":"5485918","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Treatment Outcome Study Score","conceptCode":"C127872","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-84CD-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4234-4A4C-E053-4EBD850AB273","beginDate":"2016-09-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"FerriScan","valueDescription":"FerriScan","ValueMeaning":{"publicId":"6576931","version":"1","preferredName":"FerriScan","longName":"6576931","preferredDefinition":"A proprietary method to determine liver iron concentration through an MRI-based imaging technology that uses R2-MRI relaxometry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FerriScan","conceptCode":"C153820 ","definition":"A proprietary method to determine liver iron concentration through an MRI-based imaging technology that uses R2-MRI relaxometry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C35BE4D-9060-20EB-E053-F662850A473E","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-12-04","modifiedBy":"ONEDATA","dateModified":"2018-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4284-4A4C-E053-4EBD850AB273","beginDate":"2018-12-04","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"FISH","valueDescription":"Fluorescence in Situ Hybridization","ValueMeaning":{"publicId":"5622317","version":"1","preferredName":"Fluorescence in Situ Hybridization","longName":"5622317","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C3E5FC-107A-5291-E053-F662850A2C9F","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-10","modifiedBy":"MAESKEB","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-42AE-4A4C-E053-4EBD850AB273","beginDate":"2019-04-12","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"FLAIR","valueDescription":"Fluid Attenuated Inversion Recovery","ValueMeaning":{"publicId":"6147291","version":"1","preferredName":"Fluid Attenuated Inversion Recovery","longName":"6147291","preferredDefinition":"A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluid Attenuated Inversion Recovery","conceptCode":"C82392","definition":"A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"681819F4-A298-0FC0-E053-F662850A6719","latestVersionIndicator":"Yes","beginDate":"2018-03-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-03-23","modifiedBy":"ONEDATA","dateModified":"2018-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-42B8-4A4C-E053-4EBD850AB273","beginDate":"2018-03-23","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Flow Cytometry","valueDescription":"Flow Cytometry","ValueMeaning":{"publicId":"2974014","version":"1","preferredName":"Flow Cytometry","longName":"2974014","preferredDefinition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10AD-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-42C2-4A4C-E053-4EBD850AB273","beginDate":"2013-02-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Gallium scan","valueDescription":"Gallium Scan","ValueMeaning":{"publicId":"2565861","version":"1","preferredName":"Gallium Scan","longName":"2565861","preferredDefinition":"Gallium Scan","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallium Scan","conceptCode":"C38087","definition":"A nuclear imaging procedure in which an isotope of gallium is used as the radiopharmaceutical. Gallium binds to transferrin, leukocyte lactoferrin, bacterial siderophores and inflammatory proteins and thereby can be used to localize foci of infection. It is also taken up by several tumors, thus gallium scintigraphy can be used for the staging of tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE52-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-42F4-4A4C-E053-4EBD850AB273","beginDate":"2003-05-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Gene expression profile","valueDescription":"Microarray Analysis","ValueMeaning":{"publicId":"3600806","version":"1","preferredName":"Microarray Analysis","longName":"3600806","preferredDefinition":"Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microarray Analysis","conceptCode":"C18477","definition":"Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CAC90CD8-F6FA-E6B8-E040-BB89AD4350D4","latestVersionIndicator":"Yes","beginDate":"2012-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-42FE-4A4C-E053-4EBD850AB273","beginDate":"2017-11-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Hasford","valueDescription":"Hasford Score","ValueMeaning":{"publicId":"5485917","version":"1","preferredName":"Hasford Score","longName":"5485917","preferredDefinition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hasford Score","conceptCode":"C127873","definition":"A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D7F64DB-84A8-4E54-E053-F662850A50F7","latestVersionIndicator":"Yes","beginDate":"2016-09-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4308-4A4C-E053-4EBD850AB273","beginDate":"2016-09-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Heavy chain gene rearrangement","valueDescription":"Immunoglobulin Heavy Chain Gene Rearrangement","ValueMeaning":{"publicId":"3027713","version":"1","preferredName":"Immunoglobulin Heavy Chain Gene Rearrangement","longName":"3027713v1.00","preferredDefinition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions._Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Chain","conceptCode":"C16717","definition":"A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Rearrangement Process","conceptCode":"C16611","definition":"Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81EFD3F4-AC88-C5F3-E040-BB89AD435F63","latestVersionIndicator":"Yes","beginDate":"2010-03-16","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-16","modifiedBy":"KUMMEROA","dateModified":"2023-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4312-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Histology","valueDescription":"HISTOLOGY","ValueMeaning":{"publicId":"2558883","version":"1","preferredName":"HISTOLOGY","longName":"2558883","preferredDefinition":"HISTOLOGY","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B310-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4330-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"ICE","valueDescription":"Immune Effector Encephalopathy - ICE Assessment","ValueMeaning":{"publicId":"6927187","version":"1","preferredName":"Immune Effector Encephalopathy - ICE Assessment","longName":"6927187","preferredDefinition":"A grading system for Immune Effector Cell Associated Neurotoxicity Syndrome that includes: orientation to year, month, city, hospital; ability to name objects; ability to follow simple commands; ability to write a standard sentence; and ability to count backwards from 100 by 10. Grading ranges from 10: no impairment to 0: patient unarousable and unable to perform ICE assessment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Effector Encephalopathy - ICE Assessment","conceptCode":"C162916","definition":"A grading system for Immune Effector Cell Associated Neurotoxicity Syndrome that includes: orientation to year, month, city, hospital; ability to name objects; ability to follow simple commands; ability to write a standard sentence; and ability to count backwards from 100 by 10. Grading ranges from 10: no impairment to 0: patient unarousable and unable to perform ICE assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"924E51E3-4123-3A85-E053-F662850A4336","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-09-11","modifiedBy":"ONEDATA","dateModified":"2019-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-433A-4A4C-E053-4EBD850AB273","beginDate":"2019-09-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"IgH/TCR PCR","valueDescription":"Immunoglobulin Heavy Locus T-Cell Receptor Polymerase Chain Reaction","ValueMeaning":{"publicId":"5664683","version":"1","preferredName":"Immunoglobulin Heavy Locus T-Cell Receptor Polymerase Chain Reaction","longName":"5664683","preferredDefinition":"This region represents the germline organization of the immunoglobulin heavy chain locus. The locus includes V (variable), J (joining), diversity (D), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a D segment with a J segment; a V segment is then joined to the D-J gene. The C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several D and J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink): Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI): A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly s","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Locus","conceptCode":"C26422","definition":"This region represents the germline organization of the immunoglobulin heavy chain locus. The locus includes V (variable), J (joining), diversity (D), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a D segment with a J segment; a V segment is then joined to the D-J gene. The C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several D and J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink)","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T-Cell Receptor","conceptCode":"C17065","definition":"Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48835CBD-C633-6C49-E053-F662850AD2F6","latestVersionIndicator":"Yes","beginDate":"2017-02-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-02-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4344-4A4C-E053-4EBD850AB273","beginDate":"2017-02-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Imaging","valueDescription":"Imaging","ValueMeaning":{"publicId":"5283972","version":"1","preferredName":"Imaging","longName":"5283972","preferredDefinition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3425C607-4FBC-5137-E050-BB89AD43558C","latestVersionIndicator":"Yes","beginDate":"2016-05-31","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-05-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"5.8.17 Changed NCIm concept to NCIt concept per NMDP request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4358-4A4C-E053-4EBD850AB273","beginDate":"2016-05-31","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Immunofluorescence","valueDescription":"Fluorescent Antibody Technique","ValueMeaning":{"publicId":"2978232","version":"1","preferredName":"Fluorescent Antibody Technique","longName":"2978232","preferredDefinition":"An immunological technique in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescent Antibody Procedure","conceptCode":"C17370","definition":"An immunological procedure in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C6EC2B7-FAAF-A1E4-E040-BB89AD433167","latestVersionIndicator":"Yes","beginDate":"2010-01-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-01-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4362-4A4C-E053-4EBD850AB273","beginDate":"2019-06-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Immunohistochemistry","valueDescription":"Immunohistochemistry Staining Method","ValueMeaning":{"publicId":"3031358","version":"1","preferredName":"Immunohistochemistry Staining Method","longName":"3031358","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F6B5AD-3994-79F8-E040-BB89AD430E7D","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-29","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-436C-4A4C-E053-4EBD850AB273","beginDate":"2017-05-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Immunophenotyping (4 Color flow cytometry)","valueDescription":"Four Color Flow Cytometry Immunophenotype","ValueMeaning":{"publicId":"3027791","version":"1","preferredName":"Four Color Flow Cytometry Immunophenotype","longName":"3027791","preferredDefinition":"A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.: The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.: Immunophenotype is the characterization of a set of cells according to the antigens expressed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Four","conceptCode":"C66835","definition":"A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Color","conceptCode":"C37927","definition":"The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunophenotype","conceptCode":"C20072","definition":"The characterization of a set of cells according to the antigens expressed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82018F40-F3EF-95B6-E040-BB89AD43397B","latestVersionIndicator":"Yes","beginDate":"2010-03-17","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4376-4A4C-E053-4EBD850AB273","beginDate":"2010-04-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"in situ hybridization","valueDescription":"in situ Hybridization","ValueMeaning":{"publicId":"2939763","version":"1","preferredName":"in situ Hybridization","longName":"2939763","preferredDefinition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ Hybridization","conceptCode":"C17562","definition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73532DB0-AF1C-0CB6-E040-BB89AD432D0F","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-4380-4A4C-E053-4EBD850AB273","beginDate":"2012-10-19","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Incisional biopsy","valueDescription":"INCISIONAL BIOPSY","ValueMeaning":{"publicId":"2558933","version":"1","preferredName":"INCISIONAL BIOPSY","longName":"2558933v1.00","preferredDefinition":"A surgical procedure in which part of a lesion is removed for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Incisional Biopsy","conceptCode":"C15386","definition":"A surgical procedure in which part of a lesion is removed for microscopic examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B342-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-438A-4A4C-E053-4EBD850AB273","beginDate":"2002-02-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Karyotype","valueDescription":"Karyotype","ValueMeaning":{"publicId":"5255756","version":"1","preferredName":"Karyotype","longName":"5255756","preferredDefinition":"The assessment of the chromosomal morphology and number in somatic cells of an individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyotype","conceptCode":"C25215","definition":"The chromosomal morphology and number in somatic cells of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3292EEC4-49DA-D1A2-E050-BB89AD437087","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43C6-4A4C-E053-4EBD850AB273","beginDate":"2019-04-12","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"KOH / calcofluor stain","valueDescription":"Calcofluor White Stain","ValueMeaning":{"publicId":"3181377","version":"1","preferredName":"Calcofluor White Stain","longName":"3181377","preferredDefinition":"A fluorescent stain that binds to the cell wall.  It is used for the detection of fungi, parasites, and yeasts, using fluorescent microscopy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcofluor White Stain","conceptCode":"C85880","definition":"A fluorescent stain that binds to the cell wall. It is used for the detection of fungi, parasites, and yeasts, using fluorescent microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9931591C-38E8-AF32-E040-BB89AD4346D1","latestVersionIndicator":"Yes","beginDate":"2011-01-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9A069CD-43D0-4A4C-E053-4EBD850AB273","beginDate":"2011-01-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"FDG-PET/CT","valueDescription":"Computed Tomography FDG-Positron Emission Tomography","ValueMeaning":{"publicId":"7519411","version":"1","preferredName":"Computed Tomography FDG-Positron Emission Tomography","longName":"7519411","preferredDefinition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.: An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B572C1BD-771B-4B42-E053-4EBD850AC1A0","latestVersionIndicator":"Yes","beginDate":"2020-12-01","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-01","modifiedBy":"ONEDATA","dateModified":"2020-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B572C1BD-7736-4B42-E053-4EBD850AC1A0","beginDate":"2020-12-01","endDate":null,"createdBy":"GALITG","dateCreated":"2020-12-01","modifiedBy":"ONEDATA","dateModified":"2020-12-01","deletedIndicator":"No"},{"value":"Chest X-Ray","valueDescription":"Chest Radiography","ValueMeaning":{"publicId":"2580421","version":"1","preferredName":"Chest Radiography","longName":"2580421","preferredDefinition":"An x-ray examination of the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chest Radiography","conceptCode":"C38103","definition":"An x-ray examination of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0732-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-02","modifiedBy":"ONEDATA","dateModified":"2006-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3733AB2-1159-1090-E053-4EBD850A7DFE","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"X-Ray","valueDescription":"X-Ray","ValueMeaning":{"publicId":"2970340","version":"1","preferredName":"X-Ray","longName":"2970340","preferredDefinition":"A type of high-energy radiation.  In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body.  In high doses, x-rays are used to treat cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Ray","conceptCode":"C17262","definition":"Ionizing electromagnetic radiation having a wavelength that is shorter than ultraviolet radiation and longer than gamma radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AEF9F73-937B-6ACA-E040-BB89AD435787","latestVersionIndicator":"Yes","beginDate":"2009-12-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3733AB2-116E-1090-E053-4EBD850A7DFE","beginDate":"2009-12-17","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"MIBG scintiscan","valueDescription":"Iobenguane Scan","ValueMeaning":{"publicId":"3588395","version":"1","preferredName":"Iobenguane Scan","longName":"3588395","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), localizes to adrenergic tissue and is taken up and accumulates in the granules of pre-synaptic adrenergic neurons. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.: The data or image obtained by gathering information with a sensing device.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scan","conceptCode":"C17999","definition":"The data or image obtained by gathering information with a sensing device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C96DEF2F-86D5-FD0A-E040-BB89AD4308D6","latestVersionIndicator":"Yes","beginDate":"2012-09-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3625D14-9E32-2E08-E053-4EBD850A150E","beginDate":"2020-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Chest CT","valueDescription":"Chest Computed Tomography Scan","ValueMeaning":{"publicId":"7496352","version":"1","preferredName":"Chest Computed Tomography Scan","longName":"7496352","preferredDefinition":"The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.: The data or image obtained by gathering information with a sensing device.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chest","conceptCode":"C25389","definition":"The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scan","conceptCode":"C17999","definition":"The data or image obtained by gathering information with a sensing device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B373407B-759B-0E87-E053-4EBD850A79FA","latestVersionIndicator":"Yes","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B373407B-75B4-0E87-E053-4EBD850A79FA","beginDate":"2020-11-06","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-11-06","modifiedBy":"ONEDATA","dateModified":"2020-11-06","deletedIndicator":"No"},{"value":"Post-operative brain MRI","valueDescription":"Postoperative Brain Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7808565","version":"1","preferredName":"Postoperative Brain Magnetic Resonance Imaging","longName":"7808565","preferredDefinition":"Relating to or occurring during the period immediately following a surgical operation.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Postoperative","conceptCode":"C28006","definition":"Relating to or occurring during the period immediately following a surgical operation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D00FE33D-A7F6-6060-E053-4EBD850AF04E","latestVersionIndicator":"Yes","beginDate":"2021-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-11-05","modifiedBy":"ONEDATA","dateModified":"2021-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D00FE33D-A811-6060-E053-4EBD850AF04E","beginDate":"2021-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-11-05","modifiedBy":"ONEDATA","dateModified":"2021-11-05","deletedIndicator":"No"},{"value":"Pre-operative brain MRI","valueDescription":"Preoperative Brain Magnetic Resonance Imaging","ValueMeaning":{"publicId":"7808566","version":"1","preferredName":"Preoperative Brain Magnetic Resonance Imaging","longName":"7808566","preferredDefinition":"Relating to or occurring during the period immediately before a surgical operation.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preoperative","conceptCode":"C54732","definition":"Relating to or occurring during the period immediately before a surgical operation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D00FE33D-A81F-6060-E053-4EBD850AF04E","latestVersionIndicator":"Yes","beginDate":"2021-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-11-05","modifiedBy":"ONEDATA","dateModified":"2021-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D00FE33D-A83A-6060-E053-4EBD850AF04E","beginDate":"2021-11-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-11-05","modifiedBy":"ONEDATA","dateModified":"2021-11-05","deletedIndicator":"No"},{"value":"PET-MRI","valueDescription":null,"ValueMeaning":{"publicId":"4136341","version":"1","preferredName":"Positron Emission Tomography and Magnetic Resonance Imaging","longName":"4136341","preferredDefinition":"An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography and Magnetic Resonance Imaging","conceptCode":"C103514","definition":"An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1BF5710-D107-0386-E040-BB89AD432EAD","latestVersionIndicator":"Yes","beginDate":"2014-02-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-06","modifiedBy":"KUMMEROA","dateModified":"2023-03-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7E2F17C-756D-3EB6-E053-731AD00A609D","beginDate":"2023-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-03-27","modifiedBy":"KUMMEROA","dateModified":"2023-03-27","deletedIndicator":"No"},{"value":"Resection","valueDescription":null,"ValueMeaning":{"publicId":"7060863","version":"1","preferredName":"Resection","longName":"7060863","preferredDefinition":"A surgical procedure in which tissue is removed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resection","conceptCode":"C158758","definition":"The surgical removal of an organ or a part of an organ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97B60688-9554-3965-E053-F662850AB196","latestVersionIndicator":"Yes","beginDate":"2019-11-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-11-19","modifiedBy":"ONEDATA","dateModified":"2019-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC7B7872-B204-01CB-E053-731AD00A29E7","beginDate":"2023-05-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-24","modifiedBy":"GDEEN","dateModified":"2023-05-24","deletedIndicator":"No"},{"value":"Biopsy","valueDescription":null,"ValueMeaning":{"publicId":"5043459","version":"1","preferredName":"Biopsy","longName":"5043459","preferredDefinition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24217E2F-17D1-718B-E050-BB89AD4318A8","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"LISU","dateModified":"2023-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC7B7872-B205-01CB-E053-731AD00A29E7","beginDate":"2023-05-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-24","modifiedBy":"GDEEN","dateModified":"2023-05-24","deletedIndicator":"No"},{"value":"Clinical Evaluation","valueDescription":null,"ValueMeaning":{"publicId":"6427461","version":"1","preferredName":"Clinical Evaluation","longName":"6427461v1.00","preferredDefinition":"An assessment of an individual's physical, mental, or emotional condition; information can be gathered from multiple sources, including physical exam, personal interview and observation, medical history, laboratory and imaging tests.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Evaluation","conceptCode":"C124351","definition":"An assessment of an individual's physical, mental, or emotional condition; information can be gathered from multiple sources, including physical exam, personal interview and observation, medical history, laboratory and imaging tests.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7549EEDB-439C-1886-E053-F662850A8CE3","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-09-07","modifiedBy":"GDEEN","dateModified":"2023-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC7B7872-B206-01CB-E053-731AD00A29E7","beginDate":"2023-05-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-24","modifiedBy":"GDEEN","dateModified":"2023-05-24","deletedIndicator":"No"},{"value":"Tumor marker","valueDescription":null,"ValueMeaning":{"publicId":"3830733","version":"1","preferredName":"Tumor Marker","longName":"3830733","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2D1E83A-BB6C-5A81-E040-BB89AD431072","latestVersionIndicator":"Yes","beginDate":"2013-07-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-07-31","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"00DB6A9A-41B3-4CEF-E063-731AD00A0E9F","beginDate":"2023-07-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-19","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","deletedIndicator":"No"},{"value":"FDG-PET/MRI","valueDescription":null,"ValueMeaning":{"publicId":"14640608","version":"1","preferredName":"FDG-Positron Emission Tomography Magnetic Resonance Imaging","longName":"14640608v1.00","preferredDefinition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B732AE5-72F0-6041-E063-731AD00AADE3","latestVersionIndicator":"Yes","beginDate":"2023-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-12-01","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B732AE5-72F1-6041-E063-731AD00AADE3","beginDate":"2023-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-12-01","modifiedBy":"KUMMEROA","dateModified":"2023-12-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7348632","version":"1","preferredName":"Diagnostic Assessment Method Type","preferredDefinition":"Characteristic or indicative of a condition.:The final result of a determination of the value, significance, or extent of.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25482:C25217:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnostic","conceptCode":"C25482","definition":"Characteristic or indicative of a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9A069CD-3E62-4A4C-E053-4EBD850AB273","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9A069CD-3E73-4A4C-E053-4EBD850AB273","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"KUMMEROA","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":"2023.12.1 PV added per ticket request CADSR0003140. ak 2023.8.8 PV def updated for 'No Value Exists'. ak2023.7.19 PV added per ticket requestCADSR0002626. ak  2023.3.27 PV added per ticket request CADSR0002214. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PR_PRTYP_DXMETH","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Method of evaluation:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Method used for diagnosis:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Method of diagnosis","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Diagnosis method","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F40F9AAD-7E9A-54F0-E053-731AD00ADACC","latestVersionIndicator":"Yes","beginDate":"2023-02-06","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-06","modifiedBy":"KUMMEROA","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"2023.78.26 AQT added per ticket request CADSR0002655. ak 2023.7.19 AQT/Alt SN added per ticket request CADSR0002626. ak 06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"}}